Status:
COMPLETED
Naltrexone and Memantine Effects on Alcohol Drinking Behaviors
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions:
Alcohol Drinking
Eligibility:
All Genders
21-55 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the combined effects of the study medications naltrexone and memantine on alcohol drinking behaviors.
Detailed Description
Participants will be randomized to receive a combination of naltrexone/memantine over a one week period and then participate in a laboratory session. During this session, participants are given an ini...
Eligibility Criteria
Inclusion
- Ages 21-55
- Able to read English at 6th grade level or higher and to complete study evaluations
- Regular alcohol drinker
Exclusion
- Individuals who are seeking alcohol treatment
- Medical conditions that would contraindicate the use of study medication
- Regular use of other substances
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2017
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT01519063
Start Date
January 1 2012
End Date
May 1 2017
Last Update
March 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sac, Cmhc
New Haven, Connecticut, United States, 06519